Literature DB >> 4448417

Effects of lactulose and other laxatives on ileal and colonic pH as measured by a radiotelemetry device.

R L Bown, J A Gibson, G E Sladen, B Hicks, A M Dawson.   

Abstract

Using a pH-sensitive radiotelemetering device the effect of lactulose on luminal pH in the ileum, colon, and rectum has been compared with that of two other laxative agents. Lactulose produced marked acidification of proximal colonic contents but this effect was not consistently maintained into the distal colon. Sodium sulphate acidified distal rather than proximal colonic contents. However, for a similar degree of laxation it was not possible to produce a significantly more uniform reduction of pH along the length of the colon by combining these laxatives compared with lactulose alone. Magnesium sulphate had little effect upon luminal pH except in the rectum where a significant rise occurred. These results are discussed in relation to both normal colonic physiology and to their possible relevance to the treatment of chronic hepatic encephalopathy by colonic acidification.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4448417      PMCID: PMC1413067          DOI: 10.1136/gut.15.12.999

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  19 in total

Review 1.  Lactulose.

Authors:  S G Elkington
Journal:  Gut       Date:  1970-12       Impact factor: 23.059

2.  pH profile of gut as measured by radiotelemetry capsule.

Authors:  B W Watson; S J Meldrum; H C Riddle; R L Brown; G E Sladen
Journal:  Br Med J       Date:  1972-04-08

3.  Treatment of chronic portal-systemic encephalopathy with lactulose. Report of six patients and review of the literature.

Authors:  J Bircher; U P Haemmerli; G Scollo-Lavizzari; K Hoffmann
Journal:  Am J Med       Date:  1971-08       Impact factor: 4.965

4.  Vitamin B12 uptake by human small bowel homogenate and its enhancement by intrinsic factor.

Authors:  R Carmel; A H Rosenberg; K S Lau; R R Streiff; V Herbert
Journal:  Gastroenterology       Date:  1969-03       Impact factor: 22.682

5.  Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.

Authors:  S G Elkington; M H Floch; H O Conn
Journal:  N Engl J Med       Date:  1969-08-21       Impact factor: 91.245

6.  Absorption of lactic acid from an isolated intestinal segment in the intact rat.

Authors:  M D Heller; F Kern
Journal:  Proc Soc Exp Biol Med       Date:  1968-04

7.  Some observations on the effects of treatment with lactulose on patients with chronic hepatic encephalopathy.

Authors:  R Zeegen; J E Drinkwater; J C Fenton; A Vince; A M Dawson
Journal:  Q J Med       Date:  1970-04

8.  Assessment and significance of bacterial overgrowth in the small bowel.

Authors:  J D Hamilton; N H Dyer; A M Dawson; F W O'Grady; A Vince; J C Fenton; D L Mollin
Journal:  Q J Med       Date:  1970-04

9.  Lactulose treatment of hepatic encephalopathy in outpatients.

Authors:  H Brown; C Trey; W V McDermott
Journal:  Arch Surg       Date:  1971-01

10.  Drug-induced malabsorption of vitamin B 12 . IV. Malabsorption and deficiency of B 12 during treatment with slow-release potassium chloride.

Authors:  I P Palva; S J Salokannel; T Timonen; H L Palva
Journal:  Acta Med Scand       Date:  1972-04
View more
  66 in total

1.  Effects of lactulose and lactitol on protein digestion and metabolism in conventional and germ free animal models: relevance of the results to their use in the treatment of portosystemic encephalopathy.

Authors:  S P Bird; D Hewitt; B Ratcliffe; M I Gurr
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

2.  Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon.

Authors:  Petra Louis; Sylvia H Duncan; Sheila I McCrae; Jacqueline Millar; Michelle S Jackson; Harry J Flint
Journal:  J Bacteriol       Date:  2004-04       Impact factor: 3.490

3.  Comparative study of hydrogen and methane production in the human colon using caecal and faecal homogenates.

Authors:  B Flourié; F Etanchaud; C Florent; P Pellier; Y Bouhnik; J C Rambaud
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

4.  Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileo-colonic release systems.

Authors:  Valentine C Ibekwe; Hala M Fadda; Emma L McConnell; Mandeep K Khela; David F Evans; Abdul W Basit
Journal:  Pharm Res       Date:  2008-05-09       Impact factor: 4.200

5.  Regulation of intestinal uroguanylin/guanylin receptor-mediated responses by mucosal acidity.

Authors:  F K Hamra; S L Eber; D T Chin; M G Currie; L R Forte
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

6.  Impact of pH on lactate formation and utilization by human fecal microbial communities.

Authors:  Alvaro Belenguer; Sylvia H Duncan; Grietje Holtrop; Susan E Anderson; Gerald E Lobley; Harry J Flint
Journal:  Appl Environ Microbiol       Date:  2007-08-31       Impact factor: 4.792

7.  Mesalazine release from a pH dependent formulation: effects of omeprazole and lactulose co-administration.

Authors:  F N Hussain; R A Ajjan; M Moustafa; N W Weir; S A Riley
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

8.  Mucosal surface pH of the large intestine of the rat and of normal and inflamed large intestine in man.

Authors:  N I McNeil; K L Ling; J Wager
Journal:  Gut       Date:  1987-06       Impact factor: 23.059

9.  Effect of long term lactulose ingestion on secondary bile salt metabolism in man: potential protective effect of lactulose in colonic carcinogenesis.

Authors:  G P van Berge Henegouwen; S D van der Werf; A T Ruben
Journal:  Gut       Date:  1987-06       Impact factor: 23.059

10.  Protective role of faecal pH in experimental colon carcinogenesis.

Authors:  S L Samelson; R L Nelson; L M Nyhus
Journal:  J R Soc Med       Date:  1985-03       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.